CH3 BioSystems
Methylation Biology Leader
CH3 BioSystems is a biotechnology company based on an entirely new patent-protected chemical technology designed to identify and commercialize drug and diagnostic candidates. The company offers unique cell lines for research and drug discovery. They manufacture novel molecular tools that facilitate biomedical research. Their goal is a better understanding of cancer and autoimmune, neurodevelopmental, viral and cardiovascular diseases that affect millions of people around the world.
Product Range:
- Antibodies
- Cell Lines
- Enzymes
- Peptides
- Expression Vector
- shRNA Vector
- Luciferase Reporters

Reliance Biosciences
LipoMin™ EV purification

Reed Biotech
Biological immune protein research

EnkiLife
Cell biology

Sanyou Bio
Innovative Biologics for Research and Development

Apop Biosciences
Powering cell stress detection